AHPA pushes agency on guidance
This article was originally published in The Tan Sheet
Executive Summary
FDA is urged to publish overdue guidance for reporting serious adverse events in an Oct. 4 letter by the American Herbal Products Association. Under the adverse event law that goes into effect Dec. 22, the guidance should have been published by Sept. 18, AHPA notes. "Congress clearly intended that businesses would have at least 90 days to digest the FDA's guidance and make any necessary changes" to comply with the law, the association says. AHPA also asks the agency to consider exercising enforcement discretion. AHPA provided FDA suggestions on the guidance in August (1"The Tan Sheet" Aug. 20, 2007, p. 13)...
You may also be interested in...
AHPA Asks FDA To Allow Firms To Route AER Contact To Offices Outside U.S.
FDA's guidance on adverse event reporting for OTC drugs and dietary supplements should assure that firms operating outside the country can use U.S. addresses on their product labels but receive AER-related communication in their home countries, the American Herbal Products Association recommends
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.